Bicara Therapeutics Inc.

BCAX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Oct 21, 2026
SCHEDULE 13G/A Oct 7, 2026
4 Sep 10, 2026 FORM 4
144 Sep 8, 2026
144 Sep 8, 2026
8-K Aug 25, 2026 8-K
4 Aug 14, 2026 FORM 4
3 Aug 14, 2026 FORM 3
SCHEDULE 13G/A Aug 13, 2026
4 Aug 12, 2026 FORM 4
4 Aug 12, 2026 FORM 4
4 Aug 12, 2026 FORM 4
S-8 Aug 11, 2026 S-8
10-Q Aug 11, 2026 10-Q
8-K Aug 11, 2026 8-K
144 Aug 10, 2026
144 Aug 10, 2026
144 Aug 10, 2026
4 Jul 29, 2026 FORM 4
4 Jul 29, 2026 FORM 4
3 Jul 29, 2026 FORM 3
3 Jul 29, 2026 FORM 3
8-K Jul 28, 2026 8-K
SCHEDULE 13G Jul 27, 2026
4 Jul 14, 2026 FORM 4
← Newer Page 1 of 11 · 263 filings Older →